| Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism S Jamain, H Quach, C Betancur, M Råstam, C Colineaux, IC Gillberg, ... Nature genetics 34 (1), 27-29, 2003 | 2260 | 2003 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1557 | 2018 |
| Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ... Cell 179 (7), 1469-1482. e11, 2019 | 1212 | 2019 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium Science (New York, NY) 360 (6395), eaap8757, 2018 | 722 | 2018 |
| Genome-wide scan for autism susceptibility genes A Philippe, M Martinez, M Guilloud-Bataille, C Gillberg, M Råstam, ... Human molecular genetics 8 (5), 805-812, 1999 | 570 | 1999 |
| European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment V Roessner, KJ Plessen, A Rothenberger, AG Ludolph, R Rizzo, L Skov, ... European child & adolescent psychiatry 20, 173-196, 2011 | 555 | 2011 |
| An international two–stage genome–wide search for schizophrenia susceptibility genes HW Moises, L Yang, H Kristbjarnarson, C Wiese, W Byerley, F Macciardi, ... Nature genetics 11 (3), 321-324, 1995 | 487 | 1995 |
| A genome-wide association study of anorexia nervosa V Boraska, CS Franklin, JAB Floyd, LM Thornton, LM Huckins, L Southam, ... Molecular psychiatry 19 (10), 1085-1094, 2014 | 370 | 2014 |
| Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene J Williams, G Spurlock, P McGuffin, MJ Owen, J Mallet, MM Nöthen, M Gill, ... The Lancet 347 (9011), 1294-1296, 1996 | 362 | 1996 |
| Interrogating the genetic determinants of Tourette’s syndrome and other tic disorders through genome-wide association studies D Yu, JH Sul, F Tsetsos, MS Nawaz, AY Huang, I Zelaya, C Illmann, ... American Journal of Psychiatry 176 (3), 217-227, 2019 | 342 | 2019 |
| Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism B Lerer, RH Segman, H Fangerau, AK Daly, VS Basile, R Cavallaro, ... Neuropsychopharmacology 27 (1), 105-119, 2002 | 302 | 2002 |
| Methadone versus buprenorphine in pregnant addicts: a double‐blind, double‐dummy comparison study G Fischer, R Ortner, K Rohrmeister, R Jagsch, A Baewert, M Langer, ... Addiction 101 (2), 275-281, 2006 | 285 | 2006 |
| Buprenorphine versus methadone maintenance for the treatment of opioid dependence G Fischer, W Gombas, H Eder, R Jagsch, A Peternell, G Stuhlinger, ... Addiction 94 (9), 1337-1347, 1999 | 263 | 1999 |
| Anxiety as a predictor of relapse in detoxified alcohol-dependent patients U Willinger, E Lenzinger, K Hornik, G Fischer, G Schönbeck, ... Alcohol and Alcoholism 37 (6), 609-612, 2002 | 248 | 2002 |
| Treatment of opioid‐dependent pregnant women with buprenorphine G Fischer, RE Johnson, H Eder, R Jagsch, A Peternell, M Weninger, ... Addiction 95 (2), 239-244, 2000 | 248 | 2000 |
| A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia J Williams, G Spurlock, P Holmans, R Mant, K Murphy, L Jones, A Cardno, ... Molecular psychiatry 3 (2), 141-149, 1998 | 223 | 1998 |
| Rare copy number variants in NRXN1 and CNTN6 increase risk for Tourette syndrome AY Huang, D Yu, LK Davis, JH Sul, F Tsetsos, V Ramensky, I Zelaya, ... Neuron 94 (6), 1101-1111. e7, 2017 | 200 | 2017 |
| Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders, and known risk factors N Mullins, JE Kang, AI Campos, JRI Coleman, AC Edwards, H Galfalvy, ... Biological psychiatry 91 (3), 313-327, 2022 | 198 | 2022 |
| Review and consensus on pharmacogenomic testing in psychiatry CA Bousman, SA Bengesser, KJ Aitchison, AT Amare, H Aschauer, ... Pharmacopsychiatry 54 (01), 5-17, 2021 | 175 | 2021 |
| Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia T Kapitany, K Meszaros, E Lenzinger, SD Schindler, C Barnas, K Fuchs, ... Schizophrenia research 32 (2), 101-106, 1998 | 175 | 1998 |
Friedrich LeischInstitute of Statistics, University of Natural Resources and Life Sciences, Vienna, Austriaبريد إلكتروني تم التحقق منه على boku.ac.at
